Potassium Acetate,Deicing Fluid,Acetate Potassium Salt,Potassium Ethanoate Solution Wuxi Yangshan Biochemical Co.,Ltd. , https://www.yangshanchem.com
Prostate cancer ultrasound treatment instrument market will usher in a high development trend
In the past ten years, the prevalence of prostate cancer has risen sharply in Asia and Latin America. This increase has made prostate cancer one of the most significant oncological concerns in several countries, driving rapid growth in the market for prostate cancer treatment devices.
According to available data, high-intensity focused ultrasound (HIFU) therapy devices for prostate cancer generated over $8 million in sales in Europe in 2005, and by 2008, global sales surpassed $25 million. A recent report from a U.S.-based medical consulting firm highlighted that in China, India, Japan, Singapore, South Korea, and wealthier nations in Latin America such as Brazil, Argentina, Chile, and Venezuela, the incidence of prostate cancer is rising rapidly. As a result, demand for HIFU devices in these regions is projected to double in the coming years.
Recent statistics show that in just China, India, and Japan—three of the largest economies in East Asia—millions of new prostate cancer cases are diagnosed annually. Globally, the estimated number of prostate cancer patients in Europe, North America, and Latin America exceeds 10 million.
In 2004, a U.S. company introduced a high-intensity ultrasound device for treating prostate cancer. This technology effectively targets and destroys cancerous tissue using focused sound waves, with minimal damage to surrounding areas like the urethra. Patients often experience a quicker recovery of sexual function compared to traditional methods. Experts predict that HIFU therapy will become a dominant treatment approach in the future, significantly reducing the reliance on older techniques such as cryoablation and brachytherapy, which were more commonly used in the 1990s.
As the global healthcare landscape evolves, the demand for advanced, minimally invasive treatments like HIFU continues to grow, reflecting a shift toward safer and more effective prostate cancer care.
Shanghai Medical Device Industry Association